Form 8-K - Current report:
SEC Accession No. 0001193125-25-003259
Filing Date
2025-01-08
Accepted
2025-01-08 09:06:59
Documents
16
Period of Report
2025-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d861124d8k.htm   iXBRL 8-K 32036
2 EX-99.1 d861124dex991.htm EX-99.1 9367
6 GRAPHIC g861124dsp5.jpg GRAPHIC 3369
7 GRAPHIC g861124g80s62.jpg GRAPHIC 2923
  Complete submission text file 0001193125-25-003259.txt   182736

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vor-20250106.xsd EX-101.SCH 2835
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20250106_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20250106_pre.xml EX-101.PRE 11698
18 EXTRACTED XBRL INSTANCE DOCUMENT d861124d8k_htm.xml XML 3767
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 25516773
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)